BRIEF published on 08/15/2025 at 15:20, 1 year ago Onco-Innovations atteint un taux d'exercice de mandat élevé Financement Non Dilutif Confiance Des Actionnaires Mandats Stratégie De Capital Recherche Sur Le Cancer
PRESS RELEASE published on 08/15/2025 at 15:15, 1 year ago Onco-Innovations Announces 90% of $0.60 Warrants Have Been Exercised Onco-Innovations announces successful execution of key capital strategy with over 90% of outstanding warrants exercised at $0.60, reinforcing investor confidence and internal financing effectiveness Warrants Investor Confidence Capital Strategy Onco-Innovations Internal Financing
BRIEF published on 08/13/2025 at 23:05, 1 year ago Onco-Innovations Closes $400,000 Private Placement Private Placement Securities Regulation Shares And Warrants Onco-Innovations Funding And Development
BRIEF published on 08/13/2025 at 23:05, 1 year ago Onco-Innovations clôture un placement privé de 400 000 $ Placement Privé Réglementation Des Valeurs Mobilières Actions Et Bons De Souscription Onco-Innovations Financement Et Développement
PRESS RELEASE published on 08/13/2025 at 23:00, 1 year ago Onco-Innovations Announces Closing of Private Placement Onco-Innovations Limited announces the closing of a non-brokered private placement, raising $400,000 for general corporate purposes and cancer research. Statutory hold period applies. Not for distribution in the US Non-brokered Private Placement Cancer Research Statutory Hold Period Onco-Innovations Limited Not For Distribution
BRIEF published on 08/04/2025 at 22:10, 1 year ago Onco-Innovations Sets Course for Human Trials with Avance Clinical Agreement Clinical Trial Onco-Innovations PNKP Inhibitor Avance Clinical Regulatory Preparations
BRIEF published on 08/04/2025 at 22:10, 1 year ago Onco-Innovations ouvre la voie aux essais cliniques sur l'homme grâce à un accord clinique avancé Essai Clinique Onco-Innovations Inhibiteur De PNKP Avance Clinique Préparations Réglementaires
PRESS RELEASE published on 08/04/2025 at 22:05, 1 year ago Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement Onco-Innovations partners with Avance Clinical for regulatory and clinical documentation for their PNKP inhibitor therapy. Collaboration aims to advance cancer trials Clinical Trials Cancer Research Onco-Innovations Regulatory Support Avance Clinical
BRIEF published on 07/31/2025 at 00:05, 1 year ago Inka Health to Lead AI-Driven Oncology Project with OneMedNet Clinical Trials Oncology Health Innovation Real-world Data AI Analytics
BRIEF published on 07/31/2025 at 00:05, 1 year ago Inka Health dirigera un projet d'oncologie basé sur l'IA avec OneMedNet Essais Cliniques Données Du Monde Réel Oncologie Innovation En Santé Analyse De L'IA
Published on 08/20/2026 at 10:00, 1 hour 13 minutes ago Eagle Plains' Partner Xcite Uranium Inc. Commences Drill Program at the Don Lake Uranium Project, Saskatchewan
Published on 08/20/2026 at 09:10, 2 hours 3 minutes ago HM Exploration Announces DTC Eligibility of Its Common Shares in the United States
Published on 08/20/2026 at 02:22, 8 hours 51 minutes ago Infrastructure Sterilisation Drilling Begins at Tunkillia
Published on 08/20/2026 at 00:40, 10 hours 33 minutes ago Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
Published on 08/20/2026 at 11:00, 13 minutes ago ABB Ltd: ABB share buybacks - August 13, 2026 - August 19, 2026
Published on 08/20/2026 at 10:00, 1 hour 12 minutes ago Finnvera Group Half-Year Report 1 January–30 June 2026: Export financing granted at a very high level, domestic financing below the comparison period – Capital buffers enable financing for growth, investments and exports
Published on 08/18/2026 at 18:00, 1 day 17 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day 17 hours ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 23 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 23 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 15 hours ago Aéroports de Paris S.A - July 2026 traffic figures
